Danazol—Introductory remarks

Kerstin Hagenfeldt

doi:10.3109/00016348409156989

Danazol—Introductory remarks

Kerstin Hagenfeldt

In: Acta Obstetricia et Gynecologica Scandinavica · 1984 · vol. 63(S123) , pp. 87 · doi:10.3109/00016348409156989 · PMID:6594020 · W2171469386

article OA: closed CC0 ⤵ 1 in-corpus citation

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View at publisher → View on OpenAlex View on PubMed

⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This paper provides introductory remarks on the drug danazol, a synthetic steroid derivative.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (2)

Cited by (1)

Endocrine consequences of danazol treatment in menorrhagia 1986

References (3)

A radioimmumoassay for danazol (17α-Pregna-2,4-Dien-20-Yno[2,3-d]Isoxazol-17-OL) via openalex
The absorption, distribution and metabolic fate of danazol in rats, monkeys and human volunteers. via openalex
doi:10.1530/acta.0.0470444 via openalex

Cited by (1)

Endocrine consequences of danazol treatment in menorrhagia 1986

Source provenance

openalex: last seen: 2026-05-10T18:07:45.983986+00:00

License: CC0 · commercial use OK

[1] The absorption, distribution and metabolic fate of danazol in rats, monkeys and human volunteers. 1976

[2] A radioimmumoassay for danazol (17α-Pregna-2,4-Dien-20-Yno[2,3-d]Isoxazol-17-OL) 1978